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 The primary objective of this study was to compare the anti-inflammatory effects of 
phenolic and volatile compounds extracted from cranberries. The Griess Reagent System assay 
was used to measure the in vitro anti-inflammatory capabilities of cranberry phenolic and 
volatile extracts on RAW 264.7 mouse macrophage cells. This study tested the anti-
inflammatory capabilities of the cranberry phenolic and volatile extracts before, as a preventative 
treatment, and after, as a means of treating pre-existing inflammation, inducing inflammation 
with lipopolysaccharide (LPS). All experiments were conducted in the following manner, 
varying only in whether treated with the extracts before or after LPS: 1 x 103 RAW 264.7 cells 
were seeded into individual wells of a 96 well plate, given 16 hr to attach, and treated with the 
phenolic and volatile extracts at 2x, 4x, and 8x dilutions of their respective starting 
concentrations present in a cranberry for 1 hr either before or after 24 hr of induced inflammation 
by LPS. Then, nitric oxide (NO) levels were measured to assess the anti-inflammatory 
capabilities. When treated with the extracts after LPS, the phenolic 635.7 ppm, 317.8 ppm and 
volatile 1.8 ppm NO levels were significantly lower than the positive control, reduced by 62%, 
46%, and 50% respectively. When treated before LPS, the phenolic 635.7 ppm, 317.8 ppm and 
volatile 1.8 ppm, 0.9 ppm NO levels were significantly lower than the positive control, reduced 
by 52%, 25%, 47%, and 13% respectively. Upon overall evaluation, the phenolic and volatile 
extracts’ anti-inflammatory capabilities were very comparable even though the volatiles were at 
a 353x lower concentration, and an overall stronger preventative effect was observed. Future 
studies are needed to reveal the mechanisms by which these compounds act to prevent and 
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Chapter 1: Introduction and Objectives 
1.1 Introduction 
 Inflammation is the human body’s urgent response to tissue damage caused by chemicals, 
physical injury, or pathogens (Weiss 2008). Inflammation occurs very often in humans because 
humans are partly microbial and living in a microbial world, which results in countless 
interactions with microbial stimuli and the possibility of tissue damage occurring (Nathan and 
Ding 2010). The body’s first line of defense to this tissue damage is called the acute 
inflammatory response, which is a non-specific response that mobilizes cells of the immune 
system, including macrophages, monocytes and neutrophils (Kumar et al. 2004). In a normal, 
healthy response, these immune cells arrive to the area of damage, activate the inflammatory 
response, and initiate an immune response that usually results in removal of the stimulus and 
healing of the tissue back to its’ normal functioning state (Liddiard 2011). When the acute 
inflammatory response does not resolve, that is where problems arise. Non-resolving 
inflammation, called chronic inflammation, is an extended, unregulated and maladaptive 
response involving active inflammation, attempts at tissue repair, and tissue damage (Weiss 
2008). Long-term low-grade chronic inflammation, noted by abnormally high levels of certain 
markers in the circulation including C-reactive protein, tumor necrosis factor-a, and interleukin-
6, is a risk factor for several chronic diseases (Nicklas et al. 2005). Chronic inflammation does 
not directly cause obesity, cancer, asthma, obstructive pulmonary disease, multiple sclerosis, or 
rheumatoid arthritis, but it is known to significantly contribute to their and many other diseases’ 
pathogenesis (Nathan and Ding 2010). Destructive periodontal disease, which affects the tissues 
surrounding and supporting the teeth, is another specific example of a disease involving 






inflammatory mediators tumor necrosis factor-a and interleukin-6 (Khosravi et al. 2013). 
Obesity is another example of a disease involving inflammation and is arguably the most 
relevant to people in the United States. According to the most recent report by the Center for 
Disease Control and Prevention an overwhelming 36.5% of United States adults are obese 
(Ogden et al. 2015). The inflammation associated with obesity is caused by decreased insulin 
sensitivity, increased intracellular stress, increased autophagy, hypoxia, and apoptosis, resulting 
in the release of pro-inflammatory signals (Kloting and Bluher 2014). 
 Currently, several of the treatments for chronic inflammation include taking drugs such 
as ibuprofen (Manish et al. 2003), drugs that inhibit the toll-like receptor pathway (Lucas and 
Maes 2013) and use of immunocytokines (Bootz and Neri 2016). There are other types of 
behavioral treatments, involving diet and exercise training, where the patients do not take any 
drugs, but these are newer treatments and still an active area of investigation. Nicklas et al. 
(2005) hypothesized that increased levels of adipose tissue contribute to chronic inflammation. 
They summarized and reviewed 18 published studies on the topic and found that every study 
concluded that dietary restriction leading to weight loss reduced markers of chronic 
inflammation, including tumor necrosis factor-a, C-reactive protein, interleukin-6, interleukin-8, 
interleukin-18, and others. Lee et al. (2013) corroborated that adipose tissue is an important 
regulator of inflammation, releasing pro-inflammatory, TNF-a IL-1 IL-6 and IFN-g, and anti-
inflammatory cytokines, IL-4 IL-10 IL-3 and IL-Ra. They also stated that obesity, where a 
person contains excessive amounts of adipose tissue, is an underlying condition for inflammatory 
diseases (2013).  
 Diet is a critical factor in determining the level of adipose tissue, suggesting that diet 






inflammation concluded that diets high in omega-3 fatty acids, fruits, nuts, vegetables, and whole 
grains are associated with lower levels of inflammation generated by production of anti-
inflammatory cytokines, whereas diets high in refined starches, sugar, and fats are associated 
with higher levels of inflammation generated by excessive production of pro-inflammatory 
cytokines (Giugliano et al. 2006). Glisan et al. (2016) also noted that high fat diets were coupled 
with increased toll-like receptor 4 expression and nuclear factor kB activation in monocytes, 
which triggers the inflammatory response. New methods of prevention and treatment of 
inflammation are an active area of investigation in the field, and the data from previous studies 
strongly suggest that diet plays a role in inflammation (Nicklas et al. 2005) (Lee et al. 2013), and 
that certain dietary factors can act as preventative or treatment methods to lower inflammation.   
 Fruits and vegetables have a variety of compounds associated with health benefits. 
Cranberries (Vaccinium macrocarpon L) specifically, contain many bioactive compounds known 
to improve urinary tract health, boost immune function, and reduce cardiovascular disease 
(Kresty et al. 2011). Recent research also shows cranberries have potential anti-inflammatory 
effects. In a study of hepatic inflammation in obese mice, cranberry polyphenol-rich extract 
decreased inflammatory markers tumor necrosis factor-a and chemokine ligand 2 by 28% and 
19% respectively (Glisan et al. 2016). The polyphenol-rich extract also decreased mRNA 
expression in the liver of the toll-like receptor 4 and nuclear factor kB, which are important in 
signaling pathways triggering inflammation, by 63% and 24% respectively, all over a period of 
ten weeks (2016). A study by Anhe et al. (2015) also showed anti-inflammatory effects of 
cranberry extract, specifically looking at the phenolic compounds, in high fat/high sucrose fed 
mice. Results showing that the cranberry extract fully prevented diet-induced intestinal 






aforementioned studies evaluated the cranberry extract for phenolic compounds, which likely 
have a role in the anti-inflammatory action of the extracts, but it is quite possible that other 
compounds in cranberries play a role in the berries’ anti-inflammatory effect. This possibility 
presents the purpose of this study, to explore whether the volatile compounds in cranberries also 
have anti-inflammatory properties. There has been very little research conducted specifically on 
the anti-inflammatory properties of volatile compounds extracted from cranberries, but 
previously conducted research suggests that volatile compounds overall have anti-inflammatory 
and therapeutic potential due to their ability to suppress nuclear factor kB (Salminen et al. 2008). 
Previous research also indicates that individual volatile compounds in cranberries can act as 
possible anti-inflammatory agents. α-terpineol, which is the most abundant individual volatile 
compound found in cranberries, has already shown the ability to inhibit the nuclear factor kB 
pathway (Hassan et al. 2010). This previous evidence regarding volatile compounds and the most 
abundant individual volatile compound in cranberries, α-terpineol, gives the hypothesis for the 
current study encouraging potential, that cranberry volatile and phenolic compounds reduce 
inflammation on RAW 264.7 cells, in vitro.  
1.2 Objectives 
Objective 1: Extract, quantify and identify the volatile and phenolic compounds in cranberries 
via GC and HPLC methods.  
Objective 2: Compare the anti-inflammatory effect of the volatile and phenolic extracts isolated 
from cranberries on RAW 264.7 mouse macrophage cells.  
Objective 3: Compare the anti-inflammatory effect of individual, more abundant volatile 
compounds from cranberries (α-terpineol, eucalyptol, linalool oxide, and linalool) on RAW 






Chapter 2: Literature Review 
2.1 Phenolic Compounds 
2.1.1 Functional Properties of Phenolic Compounds 
 Phenolic compounds are found in abundance in fruits, plants, herbs, vegetables, seeds, 
roots, and leaves (Soto et al. 2015). In plants, the phenolics’ main role is to protect against stress, 
but they also have a role in development, structural integrity and scaffolding, and plants’ ability 
to adapt to changing environments (Bhattacharya et al. 2010). Phenolic compounds are 
secondary plant metabolites, produced in response to stressors such as ultraviolet radiation, 
ozone, pollution, infection by pathogens, extreme temperature exposure, and tissue damage (Soto 
et al. 2015). Phenolics also contribute to the color, taste, and putative health promoting benefits 
associated with the plant producing them (Boudet 2007). Phenolic esters play a role in 
strengthening the cell wall of plants, giving texture to plant foods, and contributing to plant 
disease resistant properties (Beveridge et al. 2000) (Parr et al. 1997). The total amount of 
phenolic compounds found in a particular plant depends on factors such as growing conditions, 
cultivation techniques, cultivar, ripening processes, storage conditions, and others, and the 
phenolic content may change, increasing under the stressful conditions previously mentioned 
(Soto et al. 2015).  
2.1.2 Classification of Phenolic Compounds by Chemical Structure 
 Phenolic compounds contain one or more aromatic rings and one or more hydroxyl 
substituents by definition. These compounds are usually not found as free compounds 
(aglycones), they are most commonly esters, glycosides, or methyl esters (Soto et al. 2015). A 






contains multiple aromatic rings, and the two groups can be further classified by their side chain 
groups.  
Phenolic compounds can be formed through two different pathways, the acetic acid 
pathway and the shikimic acid pathway, forming mainly simple phenols and phenylpropanoids 
respectively (Soto et al. 2015). The “simple phenols” group can be further broken down into two 
groups, coumarins and phenolic acids. Coumarins are formed by the cyclization of o-coumaric 
acid and are glycosides. The phenolic acids contain one aromatic ring and a carboxylic acid side 
chain and they, along with their derivatives, are known for being native antioxidants (Koroleva et 
al. 2014). Caffeic acid, a specific phenolic acid derivative, is one of the most prevalent phenolic 
acids found in fruits and vegetables (Ghulam et al. 2014).  
2.1.3 Bioavailability of Phenolic Compounds 
 Phenolic compounds have been extensively studied in vitro, but it is still questioned how 
and whether the effects seen in in vitro translate in vivo. The most common phenolic compounds 
in nature are phenolic acids and flavonoids therefore the bioavailability of phenolic compounds 
can be split into groups, phenolic acids and flavonoids (Karakaya 2010). Ferulic, sinapic, p-
coumaric, and caffeic acids are all hydroxycinnamic acids, which is a subclass of phenolic acids, 
and have been found to have 25% absorption in the foregut after two hr, with a suggested 
mechanism of Na+ dependent carrier-mediated transport for absorption (Wolffram et al. 1995). In 
another study with rats fed specifically a ferulic acid rich diet, 45-53% of the dose was reported 
available for peripheral tissues, and a proportion between urinary excretion of ferulic acid and 
ferulic acid dose was determined, leading to the conclusion that the compound was highly 
absorbed (Adam et al. 2002). However, it was determined that the when the ferulic acid was in a 






(Adam et al. 2002). The bioavailability of flavonoids used to be believed as negligible due to 
being bound to glycosides, and that only aglycones could pass into the bloodstream from the gut, 
however, now several studies have demonstrated that specific flavonoids have a much higher 
bioavailability than previously thought. Quercetin has been reported at 62% dose absorption in 
the bile twenty minutes after ingestion in Wistar rats (Crespy et al. 2002). In a human study by 
Hollman et al. (1995), orally administered quercetin absorption was approximately 24% and the 
absorption of quercetin glycosides from onions, which were previously thought to be negligible, 
was 52%.  
2.2 Volatile Compounds 
2.2.1 Functional Properties of Volatile Compounds 
Volatiles are called “volatile” because they can be easily vaporized at ambient 
temperature. At ambient temperature they have a very low boiling point, or high vapor pressure. 
Fruits and vegetables produce a wide range of volatile compounds that make up their aroma, add 
to their flavor, and indicate the quality of the flavor (El Hadi et al. 2013). Although many of the 
same specific individual volatile compounds are found in different fruits and vegetables, it is the 
mixture of the volatile compounds that gives each fruit or vegetable its distinctive aroma (Tucker 
1993). Volatile compounds also serve as a defense mechanism against insect feeding in plants. In 
response to mechanical damage, the compounds are synthesized and released to ward off insects 
(Pare and Tumlinson 1999). There are several different factors that affect the volatile 
composition of a fruit or vegetable, including degree of maturity, genetic makeup, postharvest 
handling and storage, and environmental conditions (El Hadi et al. 2013).  
Volatile compounds are synthesized as secondary metabolites in fruits and vegetables, 






shredding (Gary 1999). For example, when chopping an onion, the smell is not very noticeable 
until the onion is sliced open, i.e. the tissue is disturbed, and the volatile compounds are formed 
and released. The volatiles important for the aroma and flavor of fruits and vegetables are 
biosynthesized from the following precursors: membrane lipids, amino acids, and carbohydrates 
(Sanz et al. 1997).  
2.2.2 Classification of Volatile Compounds by Chemical Structure 
 Biosynthetic pathways for the synthesis of volatile compounds can begin with fatty acids, 
amino acids, carotenoids, and terpenoids. Terpenoids are the largest class of secondary plant 
metabolites and are just one of the groups contributing to the total volatile profile. They consist 
of one or more isoprene units forming a hydrocarbon chain, and several variations including 
oxygenated, acyclic, monocyclic, and bicyclic exist. Terpenoids are commonly broken down into 
classes by the number of isoprene units in their structure. Hemiterpenoids (1 isoprene unit and 5 
carbon atoms), monoterpoids (2 isoprene units and 10 carbon atoms), sesquiterpoids (3 isoprene 
units and 15 carbon atoms), homoterpoids (2 and 3 isoprene units and 11 and 16 carbon atoms 
respectively) and a few diterpenoids (4 isoprene units and 20 carbon atoms) are the volatile 
terpenoids that have very high vapor pressure and can be released into the atmosphere (El Hadi 
et al. 2013).  
2.2.3 Biosynthesis of Volatile Compounds 
Volatile compounds are synthesized from isopentenyl diphosphate (IPP), a universal 5 
carbon precursor, and dimethylallyl diphosphate (DMAPP), IPP’s allylic isomer (El Hadi et al. 
2013). These two precursors can be produced via two different pathways in plants, the 
deoxyxylulose phosphate pathway, also called the mevalonate independent pathway, and the 






occurs in the cytosol and starts with the condensation of an acetyl coenzyme A unit to an active 
isoprene unit (IPP) (Newman and Chappell 1999). The mevalonate independent pathway (MEP 
pathway) occurs in the cell plastids and forms IPP and DMAPP from pyruvate and 
glyceraldehyde 3-phosphate and uses methylerythritol phosphate (MEP), as the key intermediate 
(Lichtenthaler 1999).  
After IPP and DMAPP are formed via these two pathways, IPP and DMAPP are 
combined in different ratios and acted upon by enzymes to create the precursors to the final 
volatile compound. A specific example of this is two molecules of IPP and one molecule of 
DMAPP being condensed in the cytosol, catalyzed by farnesyl pyrophosphate synthetase (FFPS) 
to produce farnesyl pyrophosphate, which is the natural precursor of sesquiterpenoids 
(McGarvey and Croteau 1995).  
2.3 Phenolic Compounds and Volatile Compounds in Cranberries 
2.3.1 Phenolic Compounds in Cranberries 
 Cranberries are a rich source of phenolic compounds containing flavonoid compounds 
such as flavan-3-ols/flavonols/anthocyanins, and phenolic acids such as hydroxybenzoic acid and 
hydroxycinnamic acids, along with their derivatives (Sanchez-Patan et al. 2012). The total 
phenolic makeup of cranberries contains approximately 20-25 individual phenolic compounds 
(Wang and Zuo 2011). The exact number of different individual phenolic compounds in 
cranberries vary in the literature, but hydroxybenzoic acid/ hydroxybenzoic acid derivatives, 
quercetin, and myricetin have been found by multiple studies to be the most prevalent phenolic 
compounds, and o-hydroxcinnamic acid, p-coumaric acid, caffeic acid, ferulic acids, and 
epicatechin are present in moderate amounts (Wang and Zuo 2011) (Nowak et al. 2016). Fresh 






like cranberry juice (9.1 mg/g) and cranberry sauces (11.1 mg/g) (Want and Zuo 2011). This has 
posed as an important factor to consider for studies involving the effects of intake of cranberry 
phenolic compounds because fresh cranberries have an astringent and sour taste.   
2.3.2 Volatile Compounds in Cranberries 
 Cranberry volatiles constitute several different types of compounds including aromatic 
compounds, terpenes, alcohols, and aldehydes (Croteau and Fagerson 1968). The aromatic 
compounds (benzaldehyde/benzyl/benzoate esters) and terpenes (α-terpineol) appear to be the 
major contributors to cranberry aroma, contributing to 40% and 17% of the total volatile fraction 
respectively in the study by Croteau and Fagerson (1968). Croteau and Fagerson also found that 
the terpene, α-terpineol, was the most abundant cranberry volatile, individually making up 13.6% 
of the total volatile fraction (1968). The study by Hirvi et al. (1981) mirrored these results, 
reporting aromatic compounds and terpenes making up 34% and 19% respectively, and α-
terpineol individually making up 10% of the total volatile fraction. A third study by Anjou and 
Von Sydow (1967) found the aromatic compounds and terpenes made up 31% and 40% 
respectively and individual α-terpineol 23.7% of the total volatile fraction. The percentages of 
individual volatiles in cranberries varies in the literature, but all the literature concludes that 
aromatic compounds and terpenes contribute the largest amounts to the total volatile fraction, 
and α-terpineol is individually the most abundant volatile in cranberries.  
2.4 Cranberry Consumption and Cranberry Health Benefits 
2.4.1 Cranberry Consumption 
 According to the most recent report published by the United States Department of 
Agriculture, National Agriculture Statistics Service (NASS), the total amount of fresh 






Statistics Service 2014). Only these very small amounts of fresh cranberries are consumed likely 
due to the elevated hydroxybenzoic acid and proanthocyanin contents, which gives cranberries a 
very strong and astringent taste making them unacceptable to most palates in large amounts (Nile 
and Park 2014). Cranberry products, such as dried cranberries, cranberry juices, and cranberry 
sauces, even though they have lower total levels of bioactive compounds, are much more 
practical ways to consume cranberries due to addition of sugar to the products.   
2.4.2 Cranberry Health Benefits 
 Several health benefits have been attributed to cranberry consumption including 
prevention of urinary tract infections, disruption of oral pathogen virulence and biofilm 
formation, modulation of the inflammatory response, and promotion of cardiovascular health 
(Pappas and Schaich 2009). Cranberries have also shown potential inhibiting effects on 
degenerative diseases including Alzheimer’s and cancer (Pappas and Schaich 2009).  
Prevention of urinary tract infections is the most extensively researched health benefit of 
cranberries. Urinary tract infections, in 75-95% of cases, are caused by the Escherichia coli 
pathogen adhering to the epithelial cells of the urinary tract, and the high acid content of 
cranberries prevents this adhesion to prevent infection (Zafrifri et al. 1989). Although it is now 
well accepted that cranberries aid in the prevention of urinary tract infections, the specific 
compounds in the cranberries that yield these protective properties are still up for debate.  
Cranberries have been associated with dental health by reducing bacteria in the mouth 
and preventing plaque biofilm formation. The two main bacteria in the mouth responsible for 
dental caries are Streptococcus mutans and Streptococcus sobrinus. When these bacteria co-
aggregate, they form biofilms and release acids that decay the teeth. Weiss et al. (1998) found 






Other studies later confirmed that cranberry juice inhibited co-aggregation and biofilm 
formation, associating them with possible oral health benefits, but only if the cranberry juice was 
not supplemented with sugar (Bodet et al. 2006) (Wiess et al. 2002) (Steinberg et al. 2005). The 
in vivo evidence for cranberries’ contribution to oral health is limited, but toothpastes or 
mouthwashes supplemented with cranberry phytochemicals appear to be promising.  
Recent research also shows potential for cranberries to inhibit cancer cell growth. In a 
study by Seeram et al. (2006) cranberry extracts showed the ability to inhibit cancer cell growth, 
with higher concentrations of the extracts having a higher inhibitory effect in all of the tumor cell 
lines tested, which included oral, breast, colon, and prostate cancers. In 5 out of the 6 cell lines 
studied, the cranberry extract showed a significant inhibitory effect. Cranberry had the second 
lowest IC50 value for the MCF-breast cancer cell line and the fourth lowest IC50 value for the 
CAL-2-oral cancer cell line, indicating that the cranberry extract was a very potent growth 
inhibitor in these two cases (Seeram et al. 2006). 
Consumption of cranberries is also suggested to play a role in cardiovascular health and 
neurological disease by decreasing the inflammatory response and increasing the antioxidant 
capacity in human plasma (Pappas and Schaich 2009).   
2.5 Cranberry Anti-inflammatory Properties 
2.5.1 Cranberry Phenolic Compounds Anti-inflammatory Activity 
 During inflammation, cells are faced with oxidative stress. Reactive oxygen species 
(ROS) are produced and considered one of the most potent stimuli for inflammation because they 
also stimulate the immune system monocytes/macrophages and increase the production of pro-
inflammatory cytokines TNF- α, IL-8, IL-6 and IL-1b (Sultana and Saify 2012). Cranberry 






pro-inflammatory cytokines. In the study by Mathison et al. (2014) subjects consumed acute 
doses of cranberry beverages. Blood was collected at 2-hr intervals from 0 to 8 hr and 24 hr after 
treatment and the biomarkers of antioxidant status were lower compared to starting values.  
 In the study by Bodet et al. (2006) macrophage cells were treated with a cranberry 
phenolic fraction before stimulation with lipopolysaccharide (LPS), another potent inducer of 
inflammation. After treatments with the cranberry fraction and LPS, the inflammatory markers 
TNF- α, IL-8, IL-6 and IL-1b were compared to positive and negative controls. The cranberry 
treated cells exhibited much lower levels, indicating that the cranberry fraction was a potent 
inhibitor of the pro-inflammatory responses induced by LPS.   
2.5.2 Cranberry Volatile Compounds Anti-inflammatory Activity 
There has been very little research conducted specifically on the anti-inflammatory 
properties of volatile compounds extracted from cranberries, hence the reason for this study, but 
total cranberry fractions have shown potent anti-inflammatory activity. Previously conducted 
research suggests that volatile compounds overall have anti-inflammatory and therapeutic 
potential due to their ability to suppress nuclear factor kB, a factor that controls transcription of 
DNA to produce the pro-inflammatory cytokines (Salminen et al. 2008). Previous research also 
indicates that individual volatile terpenoids in cranberries can act as possible anti-inflammatory 
agents. α-terpineol, which is by far the most abundant individual volatile compound in 
cranberries, has already shown the ability to inhibit the nuclear factor kB pathway (Hassan et al. 
2010), thus suggesting it and possibly other individual volatile terpenoids in cranberries could 






Chapter 3: Extraction, Quantification, Identification, and Free Radical-Scavenging 
Activity of Cranberry Phenolic Compounds 
3.1 Introduction 
 In the literature regarding cranberries, the cranberry phenolic compounds have been 
suggested to be responsible for the majority of the berries’ beneficial health properties, including 
their anti-inflammatory activity. This study took a different approach, suspecting other 
compounds may also contribute to cranberries’ anti-inflammatory effect. The hypothesis of this 
study was that the volatile compounds, and not just the previously hypothesized phenolic 
compounds, also have anti-inflammatory capabilities when tested in vitro on RAW 264.7 cells. 
For this study, it was necessary to evaluate the cranberry phenolic extract for its in vitro anti-
inflammatory effect on RAW 264.7 cells to be able to compare its effect to the effect of the 
volatile extract. At the time of this study, the phenolic compounds have been deemed to be the 
major bioactive source of cranberry’s anti-inflammatory properties (La et al. 2010).   
 Most methods recommend using a mixture of organic solvents and polar solvents to 
extract phenolic compounds, especially for berries high in anthocyanin content like a cranberry 
(La et al. 2010). These recommendations were followed and used to extract the phenolic 
compounds for this study and are explained in section 3.3.1.   
3.2 Materials  
 Cranberries (Stahlbush Island Farm brand) were purchased from Harps Foods, 
Fayetteville, AR. Stahlbush Island Farm is located on 5000 acres of land in the Willamette 
Valley of Oregon. The cranberries farmed there are left in the field until ripe, and frozen 






cranberries were stored unopened and frozen at -20° C until used for experimentation to avoid 
any degradation of the phenolic compounds. 
3.3 Methods 
3.3.1 Extraction of Phenolic Compounds 
 Cranberries were thawed to room temperature and rinsed with running water to remove 
any dirt/debris. Three separate phenolic extracts were prepared from fresh cranberries. 
Approximately 100 g of the rinsed cranberries were homogenized with 250 mL methanol, water, 
and formic acid using a Euro Turrax T18 Tissuemizer (Tekmar-Dohrman Corporation, Mason, 
OH) for approximately 60 sec. The homogenate was then vacuum filtered through Miracloth 
(CalBioche, LaJolla, CA) and the resulting filtrate was collected. The resulting residue was 
homogenized using the Euro Turrax Tissuemizer with 250 mL of acetic acid, water and acetone 
for approximately 60 sec. The residue homogenate was vacuum filtered through Miracloth and 
combined with the previously collected filtrate. That resulting residue was homogenized, and 
vacuum filtered the same as the previous residue. The final residue and Miracloth were rinsed 
with both solvents, methanol/water/formic acid and acetic acid/water/acetone to collect any 
remaining cranberry compounds and added to the final filtrate. The final filtrate was placed in a 
Buchi Rotary Evaporator R-114 (Buchi, Flawil, Switzerland) set at 40°C to evaporate all of the 
solvents leaving only the phenolic extract. Next, the phenolic extract was centrifuged for 5 min 
at 10,000 rpm and supernatant collected. The extract was then loaded onto a Sep-Pak® C18 
column cartridge (Waters Corporation, Milford, MA) and eluted with 70-100% ethanol until 
color was no longer visible in the cartridges. The samples were passed through 0.45 µm filters 






3.3.2 High-Performance Liquid Chromatography (HPLC) Analysis of Phenolic Compounds 
 The individual phenolic compounds from the cranberry extract were separated by HPLC 
on a 250 X 4.60 mm Symmetry 5 µm C18 column (Waters Corp, Milford, MA). The resulting 
peaks were analyzed at 320, 360, and 510 nm using a Waters Model 996 photodiode array 
detector (Waters Corp, Milford, MA). Each sample injection volume was 100 µL. Solvent A was 
the mobile phase, water acidified with phosphoric acid to pH 2.6 and methanol was used as 
solvent B. The flow rate was 1.33 mL/min, and a gradient of the solvents was used to get the best 
separation of the compounds, starting with 88% A from 0-10 minutes, 85% A from 10-26 
minutes, 40% A from 26-55 minutes, 30% A from 55-70 minutes, and 88% A from 70-85 
minutes. Detection wavelengths of 320, 360, and 510 nm was used to monitor hydroxycinnamic 
acids, flavonols and anthocyanins, respectively. Individual anthocyanin monoglucosides and 
acylated anthocyanin derivatives were quantified as Cyd (cyanidin), Pnd (peonidin), and Mvd 
(malvidin) glucoside equivalents using external calibration curves of a mix of the three 
anthocyanin glucosides. Anthocyanins were quantified as a mixture of these glucosides because 
they are naturally occurring common anthocyanidins found in nature. Hydroxycinnamic acids 
were quantified as chlorogenic acid equivalents using external calibration curves of chlorogenic 
acid and flavonols were quantified as rutin equivalents using external calibration curves of rutin. 
Results are expressed as mg of anthocyanin-3-glucoside equivalents, chlorogenic acid 
equivalents, and rutin equivalents per kg of fresh weight.  
3.3.3 Total Phenolic Content  
 The total phenolic content of the phenolic extract was measured using the Folin-Ciocalteu 
assay. First, 0.5 mL of 0.2 N Folin-Ciocalteu reagent was mixed with 0.1 mL of the cranberry 






solution was then placed into a 48-well plate in triplicate and let sit in the dark for 2 hr at room 
temperature. After the 2 hr, the absorbance of each sample was read at 760 nm. Total phenolic 
quantification was determined by comparing the absorbances of the samples to the absorbances 
of known gallic acid equivalents (GAE) at 100, 50, 25, 12.5, 6.25, and 3.125 mg per kg, which 
were prepared in the same way as the samples. Results are expressed as averages of each 
triplicate, with units of mg of GAE per kg fresh weight.  
3.3.4 DMAC (4-dimethylaminocinnamaldehyde) Total Procyanidins Assay 
 Total procyanidins present in the phenolic extract was measured using the DMAC assay 
following the methods of Payne et al. (2010). A solution of 3 mL of HCl in 27 mL alcohol was 
prepared and then 0.03 g of DMAC was added to the solution (now be referred to as DMAC 
solution). Aliquots (50 µL) of blanks, standards, and extracts were prepared. 250 µL of DMAC 
solution was added to all prepared blanks, standards, extracts. Plate was read immediately at 640 
nm. Catechin was used as the standard (2, 4, 8, 16, 32, and 64 mg/kg) with results expressed as 
mg of catechin equivalents per kg fresh weight.  
3.3.5 DPPH (2,2-diphenyl-1-picrylhydrazyl) Total Antioxidant Capacity Assay of Phenolic 
Extract 
 Total antioxidant capacity of the phenolic extract was measured using a modified DPPH 
method published by Akkari et al. (2016). 1.4 mL of a solution of DPPH in methanol was added 
to 0.1 mL of the phenolic extract at 10x, 20x, 40x, 80x, and 160x dilutions. The combined 
solution sat in the dark for 30 minutes, then absorbance on a spectrophotometer at 517 nm was 
measured. Trolox (6-hydroxy-2,5,7,8-tetramethylchromane-2-carboxylic acid) was used as the 







3.4.1 HPLC  
 
Figure 3.1 HPLC chromatogram at 360 nm measuring for flavonols 
 
 





































Table 3.1 Composition of anthocyanins, flavonols, and hydroxycinnamic acids in cranberry 
extract 
Anthocyanins (mg ACY-3-
Glu equiv. /kg FW) 
Flavonols (mg Rutin 
equiv./kg FW) 
Hydroxycinnamic acids (mg 
Chlorogenic acid equiv./kg 
FW) 
Cyd-3-gal 148.0±1.0 Myr-3-pentoside 6.7±0.0 Chlorogenic acid 14.7±0.0 
  Myr-3-pentoside 0.7±0.0   
Cyd-3-glu 2.7±0.0 Quer-3-xylo 3.4±0.0   
Cyd-3-arab 93.1±1.0 
Quer-3-
arbinopyranoside 9.2±0.0   
Mal-3-gal 8.0±2.0 Myr-3-gal 17.4±0.0   
Peo-3-gal 489.8±4.0 
Quer-3-
arabinofuranoside 3.4±0.0   
  Quer-3-gal 25.5±0.0   
Peo-3-arab 195.0±2.0 Quer-3-glu 2.7±0.0   
  Quer-3-rham 2.7±0.0   
  
Isorham-3-
hexoside 2.7±0.0   
  
Isorham-3-
pentoside 5.4±0.1   
  
Isorham-3-
pentoside 0.7±0.0   
  
Isorham-3-
pentoside 1.3±0.0   
  
Isorham-3-
pentoside 1.3±0.0   
  
Quer-3-benzoyl-
gal 0.7±0.0   
Total 




Anthocyanins were quantified using an external calibration curve of a mix of the three 
predominant anthocyanin glucosides found in cranberries; Cyd (cyanidin), Pnd (peonidin), and 
Mvd (malvidin) glucoside equivalents per kg of fresh weight. Flavonols were quantified using an 
external calibration curve of rutin and are expressed as mg of rutin equivalents per kg of fresh 
weight. Hydroxycinnamic acids were quantified using a chlorogenic acid external calibration 







3.4.2 Total Phenolic Content Using Folin-Ciocalteu Assay 
Table 3.2 Total phenolic content of cranberry extract  




dilution Total Phenolics 
Cranberry phenolics 0.3593 0.67 50 1240 
Cranberry phenolics 0.3700 0.67 50 1277 
Cranberry phenolics 0.3760 0.67 50 1297 
     
    Average 1271 
     
Total Phenolics are expressed as the triplicate average with units of mg of gallic acid equivalents 
(GAE) per kg fresh weight. 
 
3.4.3 DMAC (4-dimethylaminocinnamaldehyde) Total Procyanidins Assay 
Table 3.3 Summary statistics of DMAC analysis of phenolic extract 
 
Mean 323.6 
Std Dev 12.7 
Std Err Mean 3.0 
Upper 95% Mean 329.9 
Lower 95% Mean 317.4 
N 3 






3.4.4 DPPH (2,2-diphenyl-1-picrylhydrazyl) Free Radical-Scavenging Assay of Phenolic 
Extract 
Table 3.4 Summary statistics of DPPH analysis of phenolic extract. 
Mean 4676.4 
Std Dev 230.0 
Std Err Mean 93.9 
Upper 95% Mean 4917.7 
Lower 95% Mean 4435.1 
N 3 
      Total Antioxidant Capacity 4676.4 µM/kg+/-93.9 
3.5 Discussion 
3.5.1 HPLC Analysis Discussion 
 HPLC analysis was used to determine the composition of the anthocyanins, flavonols, 
and hydroxycinnamic acids (a subcategory of phenolic acids) present in the phenolic extract. In 
this analysis, there were seven different anthocyanin compounds present, with total anthocyanins 
equaling 936.6 ± 8.0 mg ACY-3-glucoside equiv. per kg fresh weight, sixteen different flavonol 
compounds present, with total flavonols equaling 84.4 ± 1.0 mg rutin equiv. per kg fresh weight, 
and one hydroxycinnamic acid identified, with total hydroxycinnamic acids equaling 14.7 ± 0.0 
mg chlorogenic acid equiv. per kg fresh weight (Table 3.1). It appears that the cranberry phenolic 
profile has been well mapped, because the literature is in agreeance with the results of this study. 
Although some studies reported results on dry weight basis instead of fresh weight, all studies 
reported the highest concentration of classes of compounds to be the proanthocyanidins and 
anthocyanins, at 133 g per kg dry weight and Wu et al. (2006) only looked specifically at total 
anthocyanin content and reported a value of 1400 ± 28.5 mg per kg of fresh weight, which is 






seem to differ among the literature was the number of compounds identified in the cranberry 
phenolic fraction, found to be twenty-three in this study and reported at seventeen and eleven in 
others (Seeram et al. 2006, Gregoire et al. 2007). In the study that reported only eleven highly 
purified compounds by using HPLC analysis to separate flavonols, phenolic acids, and 
proanthocyanins of cranberries they identified the following; quercetin, quercetin-3-glucoside, 
quercetin-3-galactoside, quercetin-3-arabinofuranoside, quercetin-3-rhamnoside, myricetin, 
myricetin-3-rhamnoside, epicatechin, epicatechin-(4b-8)-epicatechin, caffeic acid, and 
chlorogenic acid (Gregoire et al. 2007), and two of those were not identified in this study.  
Differences were likely due to differences in analytical procedures. Three different wavelengths 
were monitored to identify the anthocyanins, flavonols, and hydroxycinnamic acids in this study, 
whereas Gregoire et al. (2007) did not report the wavelength(s) used to identify the compounds. 
The differences among the two studies could also be due to analysis of different cranberry 
varieties. 
3.5.2 Total Phenolics by Folin-Ciocalteu Discussion 
 The total phenolic content of the cranberry extract used in this study was 1271 mg GAE 
per kg fresh weight, shown in Table 3.2. Upon comparison to other studies analyzing cranberry 
extract for total phenolics, results seem to vary. The 1271 mg GAE per kg fresh weight found in 
this study is low compared to the 1627 mg GAE per kg of fresh weight reported by Nowak et al. 
(2016). Results of this study also seem low compared to the study by Abeywickrama et al. 
(2016), who reported the total phenolics of market-mature cranberries to be ~6100 mg GAE per 
100 g dry weight. Due to the different nature of the method (fresh weight vs. dry weight) it is 
expected that the dry weight would be much higher because of concentration of the phenolic 






different varieties or cultivated in different methods resulting in the differing values for total 
phenolic content.  
3.5.3 DMAC (4-dimethylaminocinnamaldehyde) Total Procyanidins Discussion 
 Total procyanidins of the cranberry extract used in this study were found to be 324 
mg/kg. The literature reports greatly varying values, Wallace and Giusti (2010) evaluated eight 
different cranberry samples and found total procyanidins varying from 780 to 22,450 mg per kg. 
Another study found total procyanidins of cranberry extract to be 5 mg per kg, total procyanidins 
of whole cranberries to be 17 mg per kg, and total procyanidins of two cranberry juices to be 223 
and 216 mg per kg (Prior et al. 2001). The large variation in total procyanidins reported in the 
literature and found in this study could be due to different starting cranberry products (different 
varieties of fresh cranberries, freeze dried cranberries, cranberry juices ect.) and different 
extraction and analytical methods used for quantification.  
3.5.4 DPPH (2,2-diphenyl-1-picrylhydrazyl) Total Antioxidant Capacity Discussion 
 Total antioxidant capacity of the phenolic extract used in this study was found to be 4,676 
µM Trolox per kg. In the literature, using the oxygen radical absorbance capacity assay (OREC) 
cranberry anti-oxidant capacity has been reported as high as 95,840 µM Trolox equivalent per kg 
and ranked number one among fifty fruits and vegetables evaluated (Floegel et al. 2011), 
however different methods to evaluate total antioxidant capacity yield different results. The 
DPPH method in Floegel et al. (2011) study reported antioxidant capacity at 868 mg vitamin C 
equivalents per kg fresh weight, which is high compared to the other fruits and vegetables tested, 
but hard to directly compare to this study as Trolox is a vitamin E derivative. Borowska et al. 
(2009) reported the antioxidant capacity of wild cranberry to be 36,900 µM Trolox per kg and 






variation of antioxidant capacity found in this study and in the literature is likely due to differing 
cranberry varieties, different cultivar techniques, different cranberry starting products, and 
different extraction and quantification methods.  
Chapter 4: Extraction, Quantification, Identification and Free Radical-Scavenging Activity 
of Cranberry Volatile Compounds 
4.1 Introduction 
 To discover whether the volatile compounds in cranberries also have an anti-
inflammatory effect, the volatile compounds from the cranberries needed to be extracted for in 
vitro experimentation on the RAW 264.7 cells. The volatile extract also was further analyzed 
using Gas Chromatography – Mass Spectrometry (GC-MS) to determine which individual 
volatile compounds were present. Due to the instability of volatile compounds at high 
temperatures, vacuum distillation followed by rapid cooling, to avoid any degradation, was used 
for isolation of the individual volatiles (Belitz et al. 2009).   
4.2 Materials 
 Cranberries (Stahlbush Island Farm brand) were purchased from Harps Foods, 
Fayetteville, AR. Stahlbush Island Farm is located on 5000 acres of land in the Willamette 
Valley of Oregon. The cranberries farmed there are left in the field until ripe, and frozen 
immediately after harvest to seal in flavor and freshness. After purchase from Harps Foods, the 
cranberries were stored unopened and frozen at -20° C until used for experimentation to avoid 







4.3.1 Extraction of Volatile Compounds 
 Cranberries were thawed to room temperature and rinsed with running water to remove 
dirt and debris. Three separate volatile extracts were prepared from fresh cranberries. Volatiles 
were obtained by combining 300 g of berries, 300 mL deionized water, and 100 g NaCl and 
blending for one min in a Waring blender.  The homogenate was vacuum distilled at 28 in. Hg, 
50°C water bath, 0oC condenser for 30 min using a Buchi rotary evaporator (Buchi, Flawil, 
Switzerland). The first 200 mL was collected in a flask contained in an ice water bath. Additional 
ice packs were strapped to the condenser to aid in condensation and collection of volatiles. The 
final collected cranberry extract was put in a glass jar, sealed, and immediately stored in the 
freezer at -20 ºC until used for experimentation.  
4.3.2 Solid Phase Micro-extraction (SPME) of Volatiles 
 An 85µm, CAR/PDMS, Stableflex, 24 Ga, Manual Supelco (Bellefonte, PA) SPME fiber 
was used in this study.  Vials containing 4 mL of volatile extract were placed on a stir plate with 
temperature set at 65° C with the SPME fiber inserted into the headspace above the sample. 
Adsorption was timed for 30 min. Samples of volatiles (100 µL) were placed into 1 mL vials. 
After preheating for 5 min at 40oC, headspace volatiles were collected by SPME for 20 min at 
60oC using a DVB/CAR/PDMS fiber (Supleco Inc., Bellafonte, PA).  
4.3.3 GC Quantification of Volatiles 
 Volatiles adsorbed to the SPME fibers were desorbed at 270 °C for 2 min in the injection 
port of a Varian 3800 GC (Agilent Technologies, Santa Clara, CA) equipped with a HP-5 (5% 
phenyl-methylpolysiloxane) column (30 m X 250 um X 1 um) (Agilent Technologies, Santa 






injection port for 10 min after each run. The injection port was operated in splitless mode with a 
constant He flow of 25 psi. The initial oven temperature was 25° C, held for 4 min, ramped up at 
12 °C/ min to 289° C, and held at for 3 min. Volatiles were quantified as heptanal, octanal, alpha 
phellandrene, d-limonene, limonene, ocimene, nonanal, terpin-4-ol, alpha terpineol, beta 
caryophyllene, and alpha caryophyllene.  
4.3.4 GC-MS Identification of Volatiles 
 SPME-collected volatiles were analyzed by GC-MS using a Hewlett-Packard HP 5890 
series gas chromatograph equipped with a mass selective detector (MSD) and a HP-5 capillary 
column (Agilent, 30 m x 0.25 mm, film thickness 1 µm).  Working conditions included: injector 
temperature 270oC; MSD interface temperature 280oC; oven temperature programmed from -
10oC (1 min) to 280oC at 12oC/min; carrier gas (He) at a flow rate of 0.78 mL/min; injection port 
operated in splitless mode. MSD acquisition parameters included full scan mode, scan range 20-
300 m/z and scan speed 3.2 scans/s. Volatiles were identified by comparing their mass spectra 
with the spectral library (Wiley7NIST0.5), literature data, and alkane retention indices C5-C20. 
4.3.5 Total Phenolic Content  
 The total phenolic content of the volatile extract was measured using the Folin-Ciocalteu 
assay. First, 0.5 mL of 0.2 N Folin-Ciocalteu reagent was mixed with 0.1 mL of the cranberry 
volatile extract. Next, 0.4 mL of 7.5% NaHCO3 was added and mixed into the solution. The 
solution was then placed into a 48-well plate in triplicate and let sit in the dark for 2 hr at room 
temperature. After the 2 hr, the absorbance of each sample was read at 760 nm. Total phenolic 
quantification was determined by comparing the absorbances of the samples to the absorbances 






Results are expressed as averages of each triplicate, with units of mg of GAE per 100 g fresh 
weight.  
4.3.6 DPPH (2,2-diphenyl-1-picrylhydrazyl) Total Antioxidant Capacity Assay of Volatile 
Extract 
 Total antioxidant capacity of the phenolic extract was measured using a modified DPPH 
method published by Akkari et al. (2016). 1.4 mL of a solution of DPPH in methanol was added 
to 0.1 mL of the phenolic extract at 10x, 20x, 40x, 80x, and 160x dilutions. The combined 
solution sat in the dark for 30 minutes, then absorbance on a spectrophotometer at 517 nm was 
measured. Trolox (6-hydroxy-2,5,7,8-tetramethylchromane-2-carboxylic acid) was used as the 
standard (50, 100, 200, 400, 600, 800 µM) with results expressed as µM of Trolox per Kg of 
sample.  
4.4 Results 










Table 4.1 Composition of cranberry volatiles using GC-MS 
Retention Time1 (min) Volatile Compound Concentration (ppb) 
4.22 1-Butanol 18.19 
8.12 1-Pentanol 24.58 
9.1 Hexanol 24.73 
11.97 Heptanal 6.78 
13.65 1-heptanal 14.64 
13.45 Benzaldehyde 17.94 
13.87 1-octen-3-ol 16.85 
14.4 Octanal 10.87 
14.57 Alpha phellandrene 27.17 
14.98 D-limonene 22.66 
15.06 Limonene 4.20 
15.17 Eucalyptol 189.04 
15.21 Ocimene 40.25 
15.36 Ocimene 7.76 
15.63 2-octanal 110.26 
15.88 Linalool oxide 224.42 
16.35 Linalool 41.32 
16.5 Nonanal 15.46 
16.58 Nd 46.73 
18.09 Terpin-4-ol 74.36 
18.45 Alpha terpineol 2320.55 
19.46 Carvone 45.85 
19.61 Trans-2-decanal 134.20 
22.59 Beta caryophyllene 54.68 
23.21 Alpha caryophellene 58.00 
 Total Volatiles   3551.5 
Nd, not determined.  
1Retention times correspond to retention times in Figure 4.2. 
 
The results of the Folin-Ciocalteu assay measuring for total phenolics of the cranberry volatile 












Table 4.2 Summary statistics of DPPH analysis of volatile extract. 
Mean 40.2 
Std Dev 1.8 
Std Err Mean 0.72 
Upper 95% Mean 42.0 
Lower 95% Mean 38.3 
N 6 
    Total Antioxidant Capacity 40.2 µM/Kg+/-0.72 SEM 
 
4.5 Discussion 
 The chromatogram from Figures 4.1 contain a large number of peaks, which displays the 
complex aromatic composition of cranberries. 25 individual volatile compounds in the cranberry 
volatile extract used for this study were identified using Mass Spectrometry analysis and are 
listed in Table 4.1. This number of compounds is lower than other reported studies, with a 
comprehensive literature review reporting values for food volatiles compiling the data from six 
cranberry studies reporting a total of 115 volatile compounds previously identified in cranberries 
(De Vincenzi et al. 1989). In one of the studies reviewed that used American cranberry, 42 
compounds were identified, which is closer to 25 compounds identified in this study (Croteau 
and Fagerson 1968). The data from the previous studies should be compared to the current study 
with discretion, taking into account that some of the papers reviewed used cranberry juice, 
European cranberries, and cranberry press cake, which was denoted as the berry residue 
remaining after the juice has been expressed, as the starting cranberry component for evaluation, 
whereas the cranberries in this study are American cranberries grown and harvested in Oregon 






that the extracts obtained from the starting cranberry components were prepared for evaluation in 
different manners, for example Croteau and Fagerson (1968) used a cold press technique and this 
study used vacuum distillation.   
 The Folin- Ciocalteu assay was used to measure total phenolic content of the volatiles 
and the values were zero, as expected. Table 4.2 show the results of the DPPH assay, measuring 
for total antioxidant capacity, with total antioxidant capacity of the volatile extract calculated as 
40.2 uM/kg +/- 0.72. Results for both of these assays were very low as expected. These assays 
are typically not performed on volatile extracts, but they were in this study to keep consistency 
between the data collected from the phenolic extract and the volatile extract. The results 
demonstrate that the volatile fraction does not contain phenolics and the antioxidant activity of 
the volatile fraction is very low when compared with the phenolic fraction. 
Chapter 5: In Vitro Anti-Inflammatory Effect of Cranberry Phenolic and Volatile Extracts 
on RAW 264.7 cells.  
5.1 Introduction 
 To evaluate the anti-inflammatory capabilities of the cranberry phenolic and volatile 
extracts, an in vitro nitric oxide (NO) assay was performed. Nitric oxide assays are used to 
measure the total amount of nitrate/nitrite and are commonly used in experiments studying free 
radical scavenging, anti-cancer properties, anti-ageing properties, and anti-inflammatory 
properties (Kagoo and Chellathai 2014). In this case, NO levels were measured as an 
inflammatory marker. A set number of cells were treated with LPS (to stimulate inflammation 
and NO production), then treated with another substance and given time for that substance to 






cells compared to non-treated (control) were measured using colorimetric analysis to assess the 
anti-inflammatory properties of the treatments.   
 One concern that had to be addressed in methodology of this study was the solubility of 
the volatile compounds in the aqueous media. Because of the lipophilic nature of volatile 
compounds, a surfactant was needed to ensure suspension of the volatile compounds in the 
volatile treatment media. In all dilutions of the volatile treatments, there was a final 
concentration of 0.02% tween 80, a non-ionic surfactant, to ensure that the volatiles dispersed 
throughout the experimental media and were available to treat the cells. Tween 80 was chosen 
because it has been previously shown to work in cell culture and to hold volatile compounds in 
suspension in cell culture media (O’Sullivan et al. 2004). Tween 80 was found to be non-
cytotoxic to RAW 264.7 cells at the 0.02% concentration used in this study using the CellTiter 
96® Aqueous One Solution Cell Proliferation (Inah Gu, MS Thesis).   
 RAW 264.7 cells, a mouse macrophage cell line from mouse blood, were chosen for the 
NO assay because the macrophage is a major cell type involved in inflammation, and because of 
the well-known anti-inflammatory properties of cranberries (Bodet et al. 2006).  
5.2 Materials 
Cranberry phenolic and volatile extracts, explained in chapters 3 and 4 respectively, were 
used as the treatments in cell culture prior to the NO assay. The RAW 264.7 mouse macrophage 
cells were purchased from the American Type Culture Collection (ATCC, Rockville, MD) and 
cultured in Dulbecco’s modified eagle's medium (DMEM) enriched with 1% penicillin-
streptomycin, 1% L-glutamine, and 10% fetal bovine serum (FBS). The components for the 






Life Technologies (Carlsbad, CA). The Griess Reagent System kit was purchased from Promega 
Corporation (Madison, WI).  
5.3 Treatment Dosage of Cranberry Phenolic and Volatile Extracts 
 Phenolic and volatile extracts (reference chapters 3 and 4) were used as experimental 
treatments on RAW 264.7 cells before measuring the NO levels. The extracts were brought back 
to the original starting weight of the fresh cranberries so that they accurately reflect the natural 
concentrations of the phenolics and volatiles in a fresh cranberry. Due to the cells need for 
nutrient-rich media, the extracts could not be applied directly to the cells because of potential cell 
death. To keep the treatment dosage as high as possible, 2x, 4x, and 8x dilutions of the phenolic 
and volatile extracts were used. The prescribed 2x, 4x, and 8x dilutions of phenolic and volatile 
extracts were found to be non-toxic to the cells via the The CellTiter 96® AQueousOne Solution 
Cell Proliferation Assay in a preliminary study (Inah Gu, MS Thesis). 
 Treatment of the RAW 264.7 cells in this manner, with the same dilutions of phenolic 
and volatile extracts, rather than treatment with the same concentration of each extract, is 
justified by the fact that the concentrations of these compounds are not equivalent in a fresh 
cranberry. This study is representative of the amount of phenolics and volatiles that a person 
would obtain by eating fresh cranberries. Actual concentrations of treatment extracts are listed in 
Table 5.1. 
Table 5.1 Concentrations of cranberry phenolic and volatile compounds applied as treatments to 
RAW 264.7 Cells  
Treatment 1Actual Concentration 2x dilution 4x dilution 8x dilution 
Volatile Fraction 3.6 ppm 1.80 ppm 0.90 ppm 0.45 ppm 
Phenolic Fraction 1271.3 ppm 635.7 ppm 317.8 ppm 158.9 ppm 







5.4.1 Cell Culture 
RAW 264.7 mouse microphage cells were purchased from the American Type Culture 
Collection (ATCC, Rockville, MD) and cultured in Dulbecco’s modified eagle's medium 
(DMEM) enriched with 1% penicillin-streptomycin, 1% L-glutamine, and 10% fetal bovine 
serum (FBS). The cells were maintained in 75 cm2 cell culture flasks and incubated at 37 °C in a 
5% CO2 environment. All NO assays were conducted between cell passage numbers 4-8. The 
components for the DMEM media and all experimental reagents were purchased from Gibco® 
through Life Technologies (Carlsbad, CA). 
5.4.2 Griess Reagent System Assay (NO Assay) 
Nitric oxide production was analyzed using the Griess Reagent System kit containing 
nitrite standard, N-1-napthylethylenediamine dihydrochloride (NED) solution, and sulfanilamide 
solution, which was purchased from Promega Corporation (Madison, WI). 100 µL of RAW 
264.7 cells in enriched DMEM media were seeded in a 96 well plate (plate 1) and incubated at 
37 °C and 5% CO2 for 16 hr. After 16 hr, which allowed the cells to attach to bottom of the wells 
in the plate, the media was removed and treatment media containing a range of phenolic and 
volatile cranberry extracts was added, tween 80 was added at a concentration of 0.02% to the 
volatile treatment media. The treatment media was left on the cells for 1 hr, and then removed. 
Next, lipopolysaccharide (LPS) media, concentration 100 ng LPS per mL, was applied to the 
cells and left on for 24 hr. After 24 hr, the LPS media was removed and the nitric oxide levels 
were measured. To measure nitric oxide, a nitrite standard reference curve, with concentrations 
ranging from 0 to 100 µM, was prepared on a separate 96 well plate (plate 2). Samples on plate 1 






plate 2. Then, 50 µL of sulfanilamide solution was added to the standard reference curve and the 
samples on plate 2 and allowed to sit for 10 min protected from light. After ten min, 50 µL of 
NED solution was added to all wells on plate 2 and allowed to sit protected from light for 10 
min. After 10 min, the absorbance was read on a plate reader at 540 nm. After the absorbance 
readings, corrections were made to account for background absorbance of the sample control 
media. The absorbance readings were converted into nitric oxide levels using the slope value 
from the nitric oxide standard curve.  
This experiment was conducted as described above, with the cranberry treatments applied 
before the LPS, and the reverse, with the cranberry treatments applied after the LPS. For the 
reverse, the RAW 264.7 cells were seeded in the 96 well plate and allowed to sit for 16 hr. After 
16 hr the media was removed and the LPS media was applied. The LPS media was left on the 
cells for 24 hr. After 24 hr the cranberry phenolic and volatile treatment media containing the 
different concentrations was added, and a final concentration of 0.02% tween 80 was added to 
the volatile treatment media. After 1 hr with the cranberry treatment media, the plate was 
centrifuged, the supernatant transferred to a second plate, and the nitric oxide levels measured in 
the same way as described when treatments were applied before LPS.  
5.5 Statistical Analysis 
All statistical analysis was performed using JMPâ Pro Ver. 14 Statistics Software. One-
way analysis of variance for all responses for all treatment dilution combinations before and after 
by each treatment combination was ran in the Fit Y by X platform of JMP Pro Ver. 14. Multiple 
comparisons were performed using the Tukey HSD test.  
Paired t-tests were used in the Matched Pair platform of JMP Pro Ver. 14 to compare the 






5.6 Results  
5.6.1 Phenolic and Volatile Extract Treatments after Applying LPS 
 
Figure 5.1 Average NO concentration produced by RAW 264.7 cells treated with phenolic and 
volatile compounds after applying LPS. * indicates a significant difference from the positive 

























































































































-6.6141 -3.3605 -3.2148 -1.7156 0.0595 0.7510 2.3771 8.3440 
Volatile-
450 ppb 




-3.2148 -6.4684 -6.6141 -5.1150 -3.3398 -2.6483 -1.0222 4.9446 
Volatile-
900 ppb 




0.0595 -3.1941 -3.3398 -4.8390 -6.6141 -5.9226 -4.2965 1.6704 
Volatile-
900 ppb 




2.3771 -0.8765 -1.0222 -2.5214 -4.2965 -4.9880 -6.6141 -0.6472 
Control-
0x- 
8.3440 5.0904 4.9446 3.4455 1.6704 0.9788 -0.6472 -6.6141 









5.6.2 Phenolic and Volatile Extract Treatments before Applying LPS 
 
Figure 5.2 Average NO concentration produced by RAW 264.7 cells treated with phenolic and 
volatile extracts before applying LPS. * indicates a significant difference from the positive 






































































































































-2.934 -2.534 -0.459 0.064 2.978 7.858 9.101 19.235 
Volatile-
450 ppb 




-0.459 -0.859 -2.934 -2.411 0.503 5.383 6.626 16.760 
Volatile-
900 ppb 




2.978 2.579 0.503 -0.019 -2.934 1.946 3.188 13.322 
Volatile-
1.8 ppm 




9.101 8.701 6.626 6.103 3.188 -1.691 -2.934 7.200 
Control-
0x- 
19.235 18.835 16.760 16.237 13.322 8.443 7.200 -2.934 






5.6.3 Analysis of Treating After vs. Treating Before Applying LPS 
  
Control-0x- Control-0x+ 
Figure 5.3 Comparison of NO levels of controls in experiments before and after LPS. NO 

























Phenolic 635.7 ppm Phenolic 317.8 ppm 
  
Phenolic 158.9 ppm Volatile 1.8 ppm 
  
Volatile 900 ppb Volatile 450 ppb 
Figure 5.4 Comparison of NO levels treating with phenolic and volatile extracts before and after 








Upon statistical analysis of the data, the results of this study supported the proposed 
hypothesis that the volatile compounds contributed along with the phenolic compounds in the 
anti-inflammatory effect of cranberries. First, the results of application of the treatments after 
applying LPS will be discussed. Figure 5.1 along with the data listed in Table 5.2 show that 
application of cranberry phenolic and volatile extract treatments after applying LPS decreased 
NO levels compared to the positive control. The phenolic 635.7 ppm and 317.8 ppm treatments 
and the volatile 1.8 ppm treatment significantly lowered the amount of NO produced compared 
to the positive control. A relevant dose response is also shown in the results. That is as the 
dilution factor of the treatment extracts increased, the significance of the NO levels compared to 
the positive control decreased, showing that the more concentrated treatment extracts worked 
better to eliminate the pre-existing NO induced by LPS. Interestingly, the results of the phenolic 
635.7 ppm and volatile 1.8 ppm treatment extracts were not significantly different from one 
another, but were both significantly different from the positive control, indicating they had the 
same treatment effect on lowering pre-existing NO. This is important to note because although 
both extracts were prepared at a 2x dilution of the starting concentration in a cranberry, the 2x 
dilution of the volatile extract was 353x less than the concentration of the 2x dilution of the 
phenolic extract. So even at this extremely low concentration the volatile extract at 1.8 ppm 
worked just as well as the phenolic extract at 635.7 ppm at treating pre-existing NO. Also, the 
phenolic extract treatment at 635.7 ppm shared a letter with the negative control, the cells 
without any exposure to LPS, indicating that the NO levels of the phenolic 635.7 ppm extract 
treatment showed no significant difference from the cells that had no inflammation induced. P-






significant values as follows: phenolic 635.7 ppm with a p-value of 0.0014, phenolic 317.8 ppm 
with a p-value of 0.0463, and volatile 1.8 ppm with a p-value of 0.0180.  
The results of the treatment of the cells before applying LPS also supported the 
hypothesis that the volatile compounds contribute along with the phenolic compounds in the 
anti-inflammatory effect of cranberries. Figure 5.2 along with the data in Table 5.3 shows that 
application of cranberry phenolic and volatile extract treatments before applying LPS decreased 
NO levels compared to the positive control, demonstrating a preventative effect. Both phenolic 
and volatile extract treatments at 2x (635.7 ppm and 1.8 ppm respectively) and 4x dilutions 
(317.8 ppm and 900 ppb respectively) significantly lowered the amount of NO produced 
compared to the positive control. A relevant dose response is also shown in the results when the 
experiment was conducted in this manner. As the dilution factor of the treatment extracts 
increased, the significance of the NO levels compared to the positive control was reduced, 
showing that the more concentrated treatment extracts worked better to prevent the cells from 
producing NO when inflammation was induced by LPS after treatment. Interestingly, the results 
of the 2x and 4x dilutions of the phenolic and volatile extracts were not significantly different 
from one another but were all significantly different from the positive control. This indicates that 
when used as a preventative method, the phenolic and volatile treatments at the 2x dilution 
(635.7 ppm and 1.8 ppm respectively) had the same treatment effect and the phenolic and 
volatile treatments at the 4x dilution (317.8 ppm and 900 ppb respectively) had the same 
treatment effect, as opposed to only having the same treatment effect at the 2x dilution when 
applied as a treatment after the application of LPS. It is important to note again that the volatile 
extract dilution concentrations were 353x lower than the respective phenolic extract dilution 






treatments compared to the positive control are listed in Appendix B, with the significant values 
as follows: phenolic 635.7 ppm with a p-value of <.0001, phenolic 317.8 ppm with a p-value of 
<.0001, volatile 1.8 ppm with a p-value of <.0001, and volatile 900 ppb with a p-value of 0.0415.  
Upon statistical comparison of the two treatment strategies, applying the treatments 
before inducing inflammation with LPS versus applying the treatments after inducing 
inflammation with LPS, it was clear that applying the treatments before inducing inflammation 
with LPS resulted in lower NO levels in all cases (Figure 5.3 and Figure 5.4). This indicates that 
the phenolic and volatile extract treatments worked better as a preventative treatment for 
inflammation rather than a treatment for pre-existing inflammation.  
The results of the anti-inflammatory effect of the phenolic extract agreed with other 
studies where the total cranberry phenolic fraction or a specific portion of the total phenolic 
fraction tested on other cell lines, all exhibited an anti-inflammatory effect (La et al. 2010, Bodet 
et al. 2006, Feghali et al. 2012). There has been little to no research conducted on volatile 
compounds and their anti-inflammatory capabilities in vitro, so there is not any direct literature 
to compare the anti-inflammatory effect of the volatile extract.   
 The mechanisms of how the phenolic and volatile treatments work to prevent and treat 
inflammation are unclear. From the Griess Reagent System assay used in this study, only the 
levels of NO produced were measured, i.e. the amount of a specific inflammatory marker that is 
present. One possible reason for why cranberry phenolic compounds exhibit anti-inflammatory 
effects is their ability to inhibit cells from producing pro-inflammatory cytokines including 
interleukin-8 (IL-8) and chemokine ligand 5 (CCL5) and to reduce the activation of the nuclear 
factor-kB (NF-kB) p65 pathway when inflammation is induced by LPS (Bodet et al. 2006). 






antioxidant capacity, showing the extract inhibited kB kinase b, which is a central node in 
inflammatory signal transduction (Heim et al. 2012). Similar mechanisms to those reported in the 
literature could have occurred in this study following treatment with the cranberry phenolic 
extract, however the studies used different cell lines and possibly used different types of 
cranberries. The volatile compounds could be reducing the aforementioned pathways and 
cytokines in the same way, but further research is necessary to uncover that information.  
Interestingly, the antioxidant activity of the volatile extract 40 µM/Kg was much lower than that 
of the phenolic fraction, 4676 µM/Kg, indicating that suppression of oxidative stress may not 
play an important role in prevention of inflammation by the volatile fraction.  
 The NO assay has limitations, which are important to consider. Number one, the doses of 
the cranberry phenolic and volatile extracts that were used to treat the RAW 264.7 cells were 
lower than the actual concentration in a cranberry. However, the dilutions were necessary due to 
needs of the RAW 264.7 cells for media and nutrients. Even at these dilutions, some of the 
phenolic and volatile extract treatments showed a significant anti-inflammatory effect on the 
RAW 264.7 cells compared to the positive control, when treated both before and after applying 
LPS, especially at the 2x dilution (635.7 ppm phenolic and 1.8 ppm volatile) of both extracts. 
Taking into consideration that cranberries can be consumed fresh or without the dilutions 
required for this study, it is reasonable to hypothesize an even stronger anti-inflammatory effect 
could be observed in an in vivo study.  
 A second limitation of this study was the quantification of only one inflammatory marker. 
Other biological markers of inflammation include interleukin-6, TNF-a, and C-reactive protein 
(Kalogeropoulos et al. 2010) It would have been beneficial to have measured the interleukin-6 






Enzyme Linked ImmunoSorbent Assay Kit, and C-reactive protein levels using a CRP 
Quantikine Enzyme Linked ImmunoSorbent Assay kit, however, these assays were not 
performed due to time constraints.  
 Another area of limitation in this study was that the RAW 264.7 cell line used was a 
mouse macrophage cell line, not a human cell line, so possible differences could be observed in a 
human cell line. Also, this study was conducted in vitro, and the in vivo effects could be different 
if a similar study was conducted on live mice or humans. The current literature is deficient in the 
overall bioavailability of volatile compounds, and their ability to reach macrophage cells after 
ingestion from a food source, such as cranberries. A future study involving a lung cell line could 
be beneficial because volatile compounds have been previously reported to be absorbed and 
retained at close to the original dose in the lungs during inhalation (Kohlert et al. 2000).  
 Although this anti-inflammatory study had limitations, there were also strengths. Using 
multiple different concentrations of the phenolic and volatile extract treatments to see if the dose 
was relevant was beneficial to see the minimum amount of treatment required to get a significant 
change in the NO level. Another strength of this study included starting with the respective 
concentrations of phenolic and volatile compounds present in a fresh cranberry, even though they 
were not the same, to mimic the effects of the amount of phenolic and volatile compounds 
available from consuming a fresh cranberry. Testing the phenolic and volatile extracts at 
equivalent concentrations may have yielded lower levels of NO with the volatile extract, but due 
to the 353x lower concentration of volatile compounds compared to the concentration of 
phenolic compounds in cranberries, testing them in the manner used in this study mimics the 







Chapter 6: Anti-Inflammatory Effect of a-terpineol, Linalool, Linalool oxide, and 
Eucalyptol on RAW 264.7 cells in vitro.  
 
6.1 Introduction 
 A secondary objective of this study was to explore the anti-inflammatory capabilities of 
four of the most abundant individual volatile compounds found in cranberry volatile extract, a-
terpineol, linalool, linalool oxide, and eucalyptol, in vitro using the Griess Reagent System NO 
assay. The purpose of exploring each of these individual volatile compounds for their anti-
inflammatory capabilities, rather than the anti-inflammatory capabilities of the entire extract, was 
to see if certain individual volatile compounds play a larger role in reducing inflammation than 
others. Treatment dosages for this objective were determined in the same manner as all other 
treatment dosages in this study, starting from each of the individual concentrations in the total 
volatile extract, 2x, 4x, and 8x dilutions were prepared. Actual concentrations of each applied 
treatment are shown in Table 6.1.  




Concentration 2x dilution 4x dilution 8x dilution 
Alpha-terpineol 2320.6 ppb 1160.3 ppb 580.2 ppb 290.1 ppb 
Linalool oxide 224.4 ppb 112.2 ppb 56.1 ppb 28.1 ppb 
Eucalyptol 189.0 ppb 94.5 ppb 47.3 ppb 23.7 ppb 
Linalool  41.3 ppb 20.7 ppb 10.3 ppb 5.2 ppb 
1Actual concentration refers to starting concentration in total volatile extract 
6.2 Materials 
 All standard compounds a-terpineol, linalool, linalool oxide, and eucalyptol were 
purchased from Sigma Aldrich (St. Louis, MO).  The Griess Reagent System NO assay kit was 







6.3.1 Cell Culture 
RAW 264.7 mouse macrophage cells were purchased from the American Type Culture 
Collection (ATCC, Rockville, MD) and cultured in Dulbecco’s modified eagle's medium 
(DMEM) enriched with 1% penicillin-streptomycin, 1% L-glutamine, and 10% fetal bovine 
serum (FBS). The cells were maintained in 75 cm2 cell culture flasks and incubated at 37 °C in a 
5% CO2 environment. All NO assays were conducted between cell passage numbers 4-8. The 
components for the DMEM media and all experimental reagents were purchased from Gibco® 
through Life Technologies (Carlsbad, CA). 
6.3.2 Griess Reagent System Assay (NO Assay) 
Nitric oxide production was analyzed using the Griess Reagent System kit containing 
nitrite standard, N-1-napthylethylenediamine dihydrochloride (NED) solution, and sulfanilamide 
solution, which was purchased from Promega Corporation (Madison, WI). 100 µL of RAW 
264.7 cells in enriched DMEM media were seeded in a 96 well plate (plate 1) and incubated at 
37 °C and 5% CO2 for 16 hr. After 16 hr, which allowed the cells to attach to bottom of the wells 
in the plate, the media was removed and test media containing different concentrations of a-
terpineol, linalool, linalool oxide, and eucalyptol was added. The treatment media was left on the 
cells for 1 hr, and then removed. Next, lipopolysaccharide (LPS) media, concentration 100 ng 
LPS per mL, was applied to the cells and left on for 24 hr. After 24 hr, the LPS media was 
removed and the nitric oxide levels were measured. To measure the nitric oxide, a nitrite 
standard reference curve, with concentrations ranging from 0 to 100 µM, was prepared on a 
separate 96 well plate (plate 2). Samples on plate 1 were centrifuged for 1 min at 1000 rpm and 






was added to the standard reference curve and the samples on plate 2 and allowed to sit for 10 
min protected from light. After ten minutes, 50 µL of NED solution was added to all wells on 
plate 2 and allowed to sit protected from light for 10 min. After 10 min, the absorbance was read 
on a plate reader at 540 nm. After the absorbance readings, corrections were made to account for 
background absorbance of the sample control media. The absorbance readings were converted 
into nitric oxide levels using the slope value from the nitric oxide standard curve.  
This experiment was conducted as described above, with the a-terpineol, linalool, 
linalool oxide, and eucalyptol treatments applied before the LPS, and the reverse, with the 
treatments applied after the LPS. For the reverse, the RAW 264.7 cells were seeded in the 96 
well plate and allowed to sit for 16 hr. After 16 hr the media was removed and the LPS media 
was applied. The LPS media was left on the cells for 24 hr. After 24 hr the a-terpineol, linalool, 
linalool oxide, and eucalyptol treatment medias at different concentrations were added. After 1 
hr with the treatment media, the plate was centrifuged, the supernatant transferred to a second 
plate, and the nitric oxide levels measured in the same way as described when treatments were 
applied before LPS.  
6.4 Statistical Analysis 
All statistical analysis was performed using JMPâ Pro Ver. 14 Statistics Software. One-
way analysis of variance for all responses for all treatment dilution combinations before and after 
by each treatment combination was ran in the Fit Y by X platform of JMP Pro Ver. 14. Multiple 
comparisons were performed using the Tukey HSD test.  
Paired t-tests were used in the Matched Pair platform of JMP Pro Ver. 14 to compare the 







6.5 Results  
6.5.1 Standard Treatments after Applying LPS 
 
Figure 6.1 Average NO concentration produced by RAW 264.7 cells treated with a-terpineol, 
linalool, linalool oxide, and eucalyptol standards after applying LPS. * indicates a statistically 
significant difference from the positive control (CTR w/ LPS). Levels not connected by the same 










































































































































































Table 6.2.1 Means Comparisons of all pairs standard treatments after LPS using Tukey-Kramer 



















-8x -6.658 -6.265 -6.257 -6.204 -6.156 -6.085 -6.022 
Control-




-6.257 -6.649 -6.658 -6.606 -6.557 -6.487 -6.423 
Linalool-
8x -6.204 -6.597 -6.606 -6.658 -6.61 -6.539 -6.476 
Linalool-
4x -6.156 -6.548 -6.557 -6.61 -6.658 -6.588 -6.524 
Linalool-
oxide-8x -6.085 -6.478 -6.487 -6.539 -6.588 -6.658 -6.594 
Linalool-
oxide-4x -6.022 -6.414 -6.423 -6.476 -6.524 -6.594 -6.658 
Eucalyptol
-4x -5.853 -6.246 -6.255 -6.307 -6.356 -6.426 -6.49 
Linalool-
oxide-2x -2.878 -3.271 -3.279 -3.332 -3.38 -3.451 -3.514 
Linalool-




-2.318 -2.711 -2.72 -2.772 -2.821 -2.891 -2.955 
Eucalyptol




5.592 5.199 5.19 5.138 5.089 5.019 4.955 
Control-
0x- 20.552 20.159 20.151 20.098 20.05 19.979 19.916 
Positive values show pairs of means that are statistically significant. Dilution factors of 2x, 4x, 
and 8x shown after standard name have the following concentrations respectively, alpha-
terpineol 1160.3 ppb, 580.2 ppb, 290.1 ppb, linalool-oxide 112.2 ppb, 56.1 ppb, 28.1 ppb, 









Table 6.2.2 Means Comparisons of all pairs standard treatments after LPS using Tukey-Kramer 



















l-8x -5.853 -2.878 -2.608 -2.318 -1.518 5.592 20.552 
Control-




-6.255 -3.279 -3.009 -2.72 -1.919 5.19 20.151 
Linalool-
8x -6.307 -3.332 -3.062 -2.772 -1.972 5.138 20.098 
Linalool-
4x -6.356 -3.38 -3.11 -2.821 -2.02 5.089 20.05 
Linalool-
oxide-8x -6.426 -3.451 -3.181 -2.891 -2.09 5.019 19.979 
Linalool-
oxide-4x -6.49 -3.514 -3.244 -2.955 -2.154 4.955 19.916 
Eucalypto
l-4x -6.658 -3.682 -3.413 -3.123 -2.322 4.787 19.747 
Linalool-
oxide-2x -3.682 -6.658 -6.388 -6.099 -5.298 1.811 16.772 
Linalool-




-3.123 -6.099 -6.369 -6.658 -5.857 1.252 16.212 
Eucalypto




4.787 1.811 1.542 1.252 0.451 -6.658 8.302 
Control-
0x- 19.747 16.772 16.502 16.212 15.412 8.302 -6.658 
Positive values show pairs of means that are statistically significant. Dilution factors of 2x, 4x, 
and 8x shown after standard name have the following concentrations respectively, alpha-
terpineol 1160.3 ppb, 580.2 ppb, 290.1 ppb, linalool-oxide 112.2 ppb, 56.1 ppb, 28.1 ppb, 









6.5.2 Standard Treatments before Applying LPS 
 
Figure 6.2 Average NO concentration produced by RAW 264.7 cells treated with a-terpineol, 
linalool, linalool oxide, and eucalyptol standard treatments before applying LPS. * indicates a 
statistically significant difference from the positive control (CTR w/ LPS). Levels not connected 



















































































































































































Table 6.3.1 Means Comparisons of all pairs of standard treatments before LPS using Tukey-



















oxide-8x -3.054 -2.924 -2.885 -2.848 -2.759 -2.697 -2.494 
Control-
0x+ -2.924 -3.054 -3.015 -2.978 -2.889 -2.827 -2.624 
Linalool-
8x -2.885 -3.015 -3.054 -3.018 -2.929 -2.867 -2.664 
Eucalyptol
-4x -2.848 -2.978 -3.018 -3.054 -2.965 -2.903 -2.7 
Eucalyptol
-8x -2.759 -2.889 -2.929 -2.965 -3.054 -2.992 -2.789 
Linalool-
4x -2.697 -2.827 -2.867 -2.903 -2.992 -3.054 -2.851 
Linalool-




-2.433 -2.563 -2.603 -2.639 -2.728 -2.79 -2.993 
Linalool-
2x 0.347 0.217 0.177 0.141 0.051 -0.011 -0.213 
Linalool-
oxide-2x 0.413 0.283 0.243 0.207 0.118 0.056 -0.147 
Eucalyptol








3.667 3.538 3.498 3.462 3.372 3.31 3.108 
Control-
0x- 12.573 12.443 12.403 12.367 12.278 12.216 12.013 
Positive values show pairs of means that are statistically significant. Dilution factors of 2x, 4x, 
and 8x shown after standard name have the following concentrations respectively, alpha-
terpineol 1160.3 ppb, 580.2 ppb, 290.1 ppb, linalool-oxide 112.2 ppb, 56.1 ppb, 28.1 ppb, 







Table 6.3.2 Means Comparisons of all pairs of standard treatments before LPS using Tukey-





















oxide-8x -2.433 0.347 0.413 0.964 1.342 3.667 12.573 
Control-
0x+ -2.563 0.217 0.283 0.834 1.213 3.538 12.443 
Linalool-
8x -2.603 0.177 0.243 0.794 1.173 3.498 12.403 
Eucalypto
l-4x -2.639 0.141 0.207 0.758 1.137 3.462 12.367 
Eucalypto
l-8x -2.728 0.051 0.118 0.668 1.047 3.372 12.278 
Linalool-
4x -2.79 -0.011 0.056 0.606 0.985 3.31 12.216 
Linalool-




-3.054 -0.275 -0.208 0.342 0.721 3.046 11.952 
Linalool-
2x -0.275 -3.054 -2.988 -2.437 -2.058 0.267 9.172 
Linalool-
oxide-2x -0.208 -2.988 -3.054 -2.503 -2.125 0.2 9.106 
Eucalypto








3.046 0.267 0.2 -0.35 -0.729 -3.054 5.851 
Control-
0x- 11.952 9.172 9.106 8.555 8.176 5.851 -3.054 
Positive values show pairs of means that are statistically significant. Dilution factors of 2x, 4x, 
and 8x shown after standard name have the following concentrations respectively, alpha-
terpineol 1160.3 ppb, 580.2 ppb, 290.1 ppb, linalool-oxide 112.2 ppb, 56.1 ppb, 28.1 ppb, 












6.5.3 Analysis of Treating Before vs. Treating After Applying LPS 
  
Control-0x- Control-0x+ 
Figure 6.3 Comparison of NO levels of controls in experiments before and after LPS. Conc_A = 
treatment after LPS, NO Conc_B = treatment before LPS. 
 
 
   
Alpha-Terpineol 1160.3 ppb Alpha-Terpineol 580.2 ppb Alpha-Terpineol 290.1 ppb 
Figure 6.4 Comparison of NO levels treating with alpha-terpineol before and after LPS. 











   
Eucalyptol 94.5 ppb Eucalyptol 47.3 ppb Eucalyptol 23.7 ppb 
Figure 6.5 Comparison of NO levels treating with eucalyptol before and after LPS. NO_Conc_A 
= treatment after LPS, NO Conc_B = treatment before LPS. 
 
 
   
Linalool 20.7 ppb Linalool 10.3 ppb Linalool 5.2 ppb 
Figure 6.6 Comparison of NO levels treating with linalool before and after LPS. NO_Conc_A = 
treatment after LPS, NO Conc_B = treatment before LPS. 
 
   
Linalool-oxide 112.2 ppb Linalool-oxide 56.1 ppb Linalool-oxide 28.1 ppb 
Figure 6.7 Comparison of NO levels treating with linalool-oxide before and after LPS. 








 Results from the individual volatile standard treatment NO assays show potential for a-
terpineol, linalool, linalool oxide, and eucalyptol to act individually as anti-inflammatory agents, 
especially a-terpineol. The hypothesis of this secondary objective was that each of the individual 
volatile standards would have an anti-inflammatory effect compared to the positive control. The 
results of the volatile standard treatment NO assays will be discussed in two parts, first with the 
volatile standard treatments applied after inflammation was induced by LPS. Figure 6.1 along 
with the data listed in Table 6.2.1 and Table 6.2.2 show that with application of the volatile 
standard treatments after applying LPS compared to the positive control, a-terpineol at 1160.3 
ppb was the only treatment that exhibited a statistically significant lower amount of NO with a p-
value of <.0001, p-values of all treatments compared to the positive control are listed in 
Appendix B. These results are likely due to the dilutions of a-terpineol from the starting 
concentration being the highest of all the standard compounds because it was found to have the 
highest individual concentration in the cranberry total volatile extract.  
 Second, the results of the volatile standard treatments of the cells before applying LPS 
supported the hypothesis that each of the individual volatile compounds would have an anti-
inflammatory effect compared to the positive control. Figure 6.2 and with the data listed in Table 
6.3.1 and Table 6.3.2 show that with application of volatile standard treatments before applying 
LPS compared to the positive control, i.e. looking at a preventative effect, NO levels decreased 
after treatment by a-terpineol at 1160.3 ppb, a-terpineol at 580.2 ppb, linalool at 20.7 ppb, 
linalool-oxide at 112.2 ppb, and eucalyptol at 94.5 ppb. A relevant dose response is also shown 
in the results when the experiment was conducted in this manner. As the dilution factor of the 






control was reduced, showing that the more concentrated treatments were more effective in 
preventing the cells from producing as much NO when inflammation was induced by LPS after 
treatment. The a-terpineol 1160.3 ppb exhibited significantly lower NO levels that all of the 
other treatments that were statistically significant from the positive control, and the a-terpineol 
580.2 ppb was not significantly different from linalool at 20.7 ppb, linalool-oxide at 112.2 ppb, 
or eucalyptol at 94.5 ppb, indicating that all of those concentrations of volatile standard 
treatments had the same preventative anti-inflammatory capabilities. P-values of all treatments 
compared to the positive control are listed in Appendix B, with the significant values as follows: 
a-terpineol 1160.3 ppb with a p-value of <.0001, a-terpineol 580.2 ppb with a p-value of 0.0003, 
eucalyptol 94.5 ppb with a p-value of 0.0019, linalool-oxide 112.2 ppb with a p-value of 0.0184, 
and linalool 20.7 ppb with a p-value of 0.0235.  
Upon statistical comparison of the two treatment strategies, applying the treatments 
before inducing inflammation with LPS versus applying the treatments after inducing 
inflammation with LPS, applying the treatments before inducing inflammation with LPS resulted 
in lower NO levels in all cases (Figures 6.3 - 6.7). This indicated that the volatile standard 
treatments worked better as a preventative treatment for inflammation rather than a treatment for 
pre-existing inflammation.  
 The standard a-terpineol exhibited the most effective anti-inflammatory effects on the 
RAW 264.7 cells in this anti-inflammatory assay, being the only individual standard to work as 
treatment to pre-existing NO and as a treatment to prevent NO production and lowering NO 
levels compared to the control by 43.0% when applied after LPS and 43.3% when applied before 
LPS. There is no other current data reporting the anti-inflammatory effects of a-terpineol on 






inflammatory effects on other cell lines. In a study looking at epithelial buccal cells, a-terpineol 
from orange juice was found to have an anti-inflammatory effect by reducing IL-6 production by 
inhibiting the gene expression of the IL-6 receptor (Held et al. 2007). In another study on U937 
human macrophage cells looking at tea tree oil steam distilled from Melaleuca alternifolia that 
contains a-terpineol, the inflammation markers IL-b1, IL-6, and IL-10 induced by LPS were 
found to be significantly reduced by treatment of the cells with the tea tree oil, and the 
mechanism for the inhibition of the inflammatory markers was that the tea tree oil extract 
components, specifically noted as a-terpineol and terpinen-4-ol, interfered with the NF-kB, p38, 
extracellular signal-regulated kinase (ERK), or mitogen-activated protein kinase (MAPK) 
pathways (Nogueira et al. 2014). In the present study, it is possible that these same pathways 
were inhibited upon treatment with a-terpineol, but the differences in cell lines and source of the 
a-terpineol must be considered upon comparison.  
 The standard eucalyptol exhibited an anti-inflammatory effect in the present study only 
when applied to the RAW 264.7 cells as a treatment before inducing inflammation with LPS, 
lowering NO levels by 25.4% compared to the positive control. There is no other current data 
reporting the anti-inflammatory effects of eucalyptol on RAW 264.7 cells for comparison, 
however eucalyptol has been shown to have anti-inflammatory effects. In an in vivo study on 
mice, eucalyptol was found to inhibit the production of TNF-a, IL-b1, and IL-6 induced by 
injection of complete Freund’s adjuvants, CFA, by a mechanism dealing with the transient 
receptor potential cation channel subfamily M member 8, TRPM8, (Caceres et al. 2017). In 
another study by Caceres Bustos et al. (2016), working on lung cells of mice, LPS was used to 
induce inflammation, and after 24 hr, the lungs and bronchoalveolar lavage of eucalyptol treated 






only the TRPM8 wild-type mice exhibited anti-inflammatory effects, showing that TRPM8 was 
essential for eucalyptol to exhibit its anti-inflammatory capabilities. In another study involving 
eucalyptol and inflammation on a different cell type, but similar time frame and induction of 
inflammation to the present study, mice were intraperitoneally injected with eucalyptol one hr 
before being challenged with LPS and compared to controls. The eucalyptol injected mice had 
lower levels of TNF-a, IL-6, NO, and NF-kB (Kim et al. 2015). These studies support the data 
in the present study that eucalyptol works as a suppressor of anti-inflammatory markers when 
used as a pre-treatment to induced inflammation, and also that the mechanism for the anti-
inflammatory properties of eucalyptol in this study could have involved TRPM8, however 
comparisons between the studies must be done with caution due to the use of different cell lines. 
Confirmation of the mechanisms and suppression of other anti-inflammatory markers besides 
NO on RAW 264.7 cells warrants future research.  
 The standard linalool-oxide exhibited an anti-inflammatory effect in the present study 
only when applied to the RAW 264.7 cells as a treatment before inducing inflammation with 
LPS, lowering NO levels by 21.8% compared to the positive control. There is no other current 
data reporting the anti-inflammatory effects of linalool-oxide for comparison, therefore the 
mechanisms and the ability to suppress other anti-inflammatory markers in RAW 264.7 cells 
warrants future research.  
 The standard linalool exhibited an anti-inflammatory effect in the present study only 
when applied to the RAW 264.7 cells as a treatment before inducing inflammation with LPS, 
lowering NO levels by 21.4% compared to the positive control. There is one other current study 
reporting the anti-inflammatory effects of linalool on RAW 264.7 cells for comparison. Huo et 






on a lung injury model and found that linalool lowered the production of TNF-a, and IL-6 in 
vitro and in vivo compared to controls. This study looked at different biological markers of 
inflammation than the present study but confirms the preventative effect of linalool on RAW 
264.7 cells as a treatment for inflammation. There are other studies that have looked at linalool 
and the anti-inflammatory effect. In a study evaluating the anti-inflammatory effects of linalool 
from Cinnamomum osmophloeum Kanehira, a Taiwan native plant, mice were administered 
linalool at 2.6 and 5.2 mg per kg of body weight before injected with endotoxin to induce 
inflammation, and the mice treated with linalool were found to have decreased levels of the 
inflammatory markers peripheral nitrate and nitrite, IL-1b, IL-18, TNF-a, and IFN-l (Lee et al. 
2018) Contrary to the anti-inflammatory effect found in the present study and other current 
studies, in the study by Held et al. (2007) linalool identified in orange juice was found to have no 
effect on the production of the pro-inflammatory cytokine IL-6, and was found to have no 
inhibition of gene expression of the IL-6 receptor in epithelial buccal cells and overall no anti-
inflammatory effect. However, the results from this study were found using linalool isolated 
from orange juice and evaluated on a different cell line, which could have led to the differing 
results. The mechanisms by which linalool acts as an anti-inflammatory treatment on RAW 
264.7 cells has yet to be determined and warrants further research.  
 The NO assay used for experimentation in the present study had some limitations. First, it 
is hard to compare the effects of the treatments of a-terpineol, linalool, linalool oxide, and 
eucalyptol directly with each other because they were applied as treatments on the RAW 264.7 
cells at different concentrations. However, different concentrations were necessary to keep 
consistent with the rest of the study and to be as representative as possible of the concentrations 






this study would translate in vivo in humans, because a mouse cell line was used and the ability 
of a-terpineol, linalool, linalool oxide, and eucalyptol to get into macrophages in humans has not 
been determined and warrants future research. Third, the exact mechanisms by which a-
terpineol, linalool, linalool oxide, and eucalyptol provided their respective anti-inflammatory 
effects in this study were not tested, and other experimental assays along with the NO assay 
could have been conducted to determine levels of other inflammatory markers.  
Chapter 7: Final Conclusions 
 Three objectives were addressed in the present study, number one was to extract, quantify 
and identify the volatile and phenolic compounds in cranberries. Number two was to compare 
the anti-inflammatory effect of the volatile and phenolic extracts from cranberries on RAW 
264.7 mouse macrophage cells, and number three was to compare the anti-inflammatory effect of 
four individual, more abundant volatile compounds from cranberries, α-terpineol, eucalyptol, 
linalool oxide, and linalool, on RAW 264.7 mouse macrophage cells. 
 For objective number one, the Folin-Ciocalteu assay and HPLC were used. The total 
phenolic content of the cranberries in this study was 1271 mg GAE equiv. per kg fresh weight. 
Using HPLC, the concentration of total anthocyanins was found to be 936.6 ± 8.0 mg ACY-3-glu 
equiv. per kg of fresh weight, the concentration of total flavonols was found to be 84.4 ± 1.0 mg 
rutin equiv. per kg of fresh weight, and the concentration of total hydroxycinnamic acids was 
found to be 14.7 ± 0.0 mg chlorogenic acid equiv. per kg of fresh weight. The total volatile 
content of the cranberries used in this study was 3551.5 ppb. Using GC-MS, 25 individual 
volatile compounds were identified, with the more prevalent individual compounds being a-






which agreed with other cranberry studies finding a-terpineol to make up the majority of the 
volatile fraction of cranberries. 
 For objective number two, the Griess Reagent System assay was used to measure NO 
levels produced in vitro by RAW 264.7 cells when treated with volatile and phenolic extracts 
before and after inducing inflammation using LPS. When the cells were treated with phenolic 
and volatile extracts after inducing inflammation with LPS, the phenolic extract treatments and 
the 1.8 ppm volatile extract treatment showed statistically significant, lower NO levels compared 
to the positive control. When the cells were treated with phenolic and volatile extracts before 
inducing inflammation with LPS, the 635.7 ppm and 317.8 ppm phenolic extract treatments and 
1.8 ppm and 0.9 ppm volatile extract treatments showed statistically significant, lower NO levels 
compared to the positive control. Treating the cells with the phenolic and volatile extracts before 
inducing inflammation with LPS resulted in lower levels of NO in all treatments. Results 
indicate that the total phenolic and volatile extracts from a cranberry act as an effective preventer 
of inflammation and an effective treatment for pre-existing inflammation.  
 For the last objective, the Griess Reagent System assay was used to measure NO levels 
produced in vitro by RAW 264.7 cells when treated with a-terpineol, linalool, linalool oxide, 
and eucalyptol before and after inducing inflammation using LPS. When the cells were treated 
with a-terpineol, linalool, linalool oxide, and eucalyptol after inducing inflammation with LPS, 
only the 1160.3 ppb a-terpineol resulted in statistically significant, lower NO levels compared to 
the positive control. However, when the cells were treated before LPS, a-terpineol 1160.3 ppb 
and 580.2 ppb, linalool 20.7 ppb, linalool oxide112.2 ppb, and eucalyptol 94.5 ppb all showed 






 Future research is warranted to determine the mechanisms by which all treatments in this 
study exhibited their respective anti-inflammatory effects. Uncovering the mechanisms by which 
these treatments lower inflammation could aid in the treatment of diseases involving 
inflammation such as obesity and periodontal disease. Future research is also necessary to 
determine the bioavailability of cranberry volatile compounds, because as of now it is unknown 
whether they can reach macrophage cells in humans at high enough doses to elicit the effects 
seen in this in vitro study. Other recommendations for future research would be to re-run the 
current study and measure additional inflammatory markers such as IL-6, TNF-a, and C-reactive 
protein, and to investigate the possible synergistic effects of combinations of the volatile 
standards, volatile extract, and phenolic extract. 
 In final summary, the most relevant finding of this study is that the volatile compounds 
extracted from cranberries have a similar anti-inflammatory effect to the phenolic compounds at 
a 353x lower concentration, whereas all previous studies have attributed the health benefits of 
cranberries to phenolic compounds. These results provide exciting information for future 
prevention and treatment of inflammation, as cranberries are low cost and easy to obtain in the 
United States. Taking into consideration that all fruits and vegetables contain some level of these 
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Appendix B: P-values for all statistical analysis 
Table 1 p-values of phenolic and volatile treatments after LPS compared to positive control.  
* indicates significance. 
Level  - Level Difference Std Err Dif p-Value 
Control-0x+ Control-0x- 14.95807 2.141153 <.0001* 
Control-0x+ Phenolic-2x  8.9912 2.141153 0.0014* 
Control-0x+ Volatile-2x 7.36513 2.141153 0.0180* 
Control-0x+ Phenolic-4x 6.6736 2.141153 0.0463* 
Control-0x+ Volatile-4x 4.89847 2.141153 0.3096 
Control-0x+ Phenolic-8x 3.39933 2.141153 0.7567 
Control-0x+ Volatile-8x 3.2536 2.141153 0.7954 
 
 
Table 2 p-values of phenolic and volatile treatments before LPS compared to positive control.  
* indicates significance. 
Level  - Level Difference Std Err Dif p-Value 
Control-0x+ Control-0x- 22.1686 0.9497967 <.0001* 
Control-0x+ Phenolic-2x 12.03447 0.9497967 <.0001* 
Control-0x+ Volatile-2x 10.792 0.9497967 <.0001* 
Control-0x+ Phenolic-4x 5.91233 0.9497967 <.0001* 
Control-0x+ Volatile-4x 2.99787 0.9497967 0.0415* 
Control-0x+ Phenolic-8x 2.47493 0.9497967 0.1649 








Table 3 p-values of standards treatments after LPS compared to positive control.  
* indicates significance. 
Level  - Level Difference Std Err Dif p-Value 
Control-0x+ Control-0x- 26.81753 1.960337 <.0001* 
Control-0x+ Alpha-Terpineol-2x 11.8572 1.960337 <.0001* 
Control-0x+ Eucalyptol-2x 4.74773 1.960337 0.4684 
Control-0x+ Alpha-Terpineol-4x 3.947 1.960337 0.7575 
Control-0x+ Linalool-2x 3.6574 1.960337 0.8422 
Control-0x+ Linalool-oxide-2x 3.3876 1.960337 0.9035 
Control-0x+ Eucalyptol-4x 0.41193 1.960337 1 
Control-0x+ Eucalyptol-8x 0.39287 1.960337 1 
Control-0x+ Linalool-oxide-4x 0.24367 1.960337 1 
Control-0x+ Linalool-oxide-8x 0.18 1.960337 1 
Control-0x+ Linalool-4x 0.10967 1.960337 1 
Control-0x+ Linalool-8x 0.06113 1.960337 1 





















Table 4 p-values of standards treatments before LPS compared to positive control.  
* indicates significance. 
Level  - Level Difference Std Err Dif p-Value 
Control-0x+ Control-0x- 15.49727 0.8992653 <.0001* 
Control-0x+ Alpha-Terpineol-2x 6.59193 0.8992653 <.0001* 
Control-0x+ Alpha-Terpineol-4x 4.26693 0.8992653 0.0003* 
Control-0x+ Eucalyptol-2x 3.888 0.8992653 0.0019* 
Control-0x+ Linalool-oxide-2x 3.3372 0.8992653 0.0184* 
Control-0x+ Linalool-2x 3.27107 0.8992653 0.0235* 
Control-0x+ Alpha-Terpineol-8x 0.49133 0.8992653 1 
Control-0x+ Linalool-oxide-4x 0.43013 0.8992653 1 
Control-0x+ Linalool-4x 0.22733 0.8992653 1 
Control-0x+ Eucalyptol-8x 0.16533 0.8992653 1 
Control-0x+ Linalool-oxide-8x 0.1298 0.8992653 1 
Control-0x+ Eucalyptol-4x 0.07613 0.8992653 1 
Control-0x+ Linalool-8x 0.03973 0.8992653 1 
 
 
 
